Abstract
Gitelman syndrome is an autosomal recessive salt-wasting tubulopathy caused by mutations in the SLC12A3 gene. A female and a male sibling from two unrelated Greek-Cypriot families presenting with a severe salt-wasting tubulopathy due to compound heterozygous mutations of a novel duplication and a previously reported missense mutation in the SLC12A3 gene are described. Sanger sequencing was used to identify possible mutations in the SLC12A3 gene. For the detection of duplications/conversions and deletions in the same gene, Multiplex ligation probe amplification (MLPA) analysis was performed. Direct sequencing and MLPA analysis of the SLC12A3 gene identified two compound heterozygous mutations in both unrelated probands. Both probands were identified to carry in compound heterozygosity the known p.Met581Lys and a novel heterozygous duplication of exons 9-14 (E9_E14dup). The diagnosis of Gitelman syndrome was made through clinical assessment, biochemical screening and genetic analysis. The identification of the novel SLC12A3 duplication seems to be characteristic of Greek-Cypriot patients and suggests a possible ancestral mutational event that has spread in Cyprus due to a possible founder effect. Testing for Gitelman syndrome probable variants can be performed before proceeding to a full gene sequencing dropping the diagnostic cost. In addition, this report adds to the mutational spectrum observed.
This is a preview of subscription content, log in via an institution to check access.
References
Ashton E. J., Legrand A., Benoit V., Roncelin I., Venisse A., Zennaro M. C. et al. 2018 Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies. Kidney Int. 93, 961–967.
Belancio V. P., Hedges D. J. and Deininger P. 2008 Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res. 18, 343–358.
Blanchart A., Fernando R., Haring M., Assaife-Lopes N., Romanov R. A., Andang M. et al. 2017 Endogenous GABAA receptor activity suppresses glioma growth. Oncogene 36, 777–786.
Colussi G., Bettinelli A., Tedeschi S., De Ferrari M. E., Syren M. L., Borsa N. et al. 2007 A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin. J. Am. Soc. Nephrol. 2, 454–460.
Cruz D. N., Shaer A. J., Bia M. J., Lifton R. P., Simon D. B., Yale G. S. et al. 2001 Gitelman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 59, 710–717.
Fanis P., Skordis N., Frangos S., Christopoulos G., Spanou-Aristidou E., Andreou E. et al. 2018 Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect. J. Endocrinol. Invest. 41, 1149–1157.
Gamba G. 2005 Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiol. Rev. 85, 423–493.
Nakhoul F., Nakhoul N., Dorman E., Berger L., Skorecki K. and Magen D. 2012 Gitelman’s syndrome: a pathophysiological and clinical update. Endocrine 41, 53–57.
Riveira-Munoz E., Chang Q., Godefroid N., Hoenderop J. G., Bindels R. J., Dahan K. et al. 2007 Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J. Am. Soc. Nephrol. 18, 1271–1283.
Simon D. B., Nelson-Williams C., Bia M. J., Ellison D., Karet F. E., Molina A. M. et al. 1996 Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat. Genet. 12, 24–30.
Skordis N., Neocleous V., Kyriakou A., Efstathiou E., Sertedaki A., Philibert P. et al. 2010 The IVS1-2A\(>\)G mutation in the SRD5A2 gene predominates in Cypriot patients with 5alpha reductase deficiency. J. Endocrinol. Invest. 33, 810–814.
Vargas-Poussou R., Dahan K., Kahila D., Venisse A., Riveira-Munoz E., Debaix H. et al. 2011 Spectrum of mutations in Gitelman syndrome. J. Am. Soc. Nephrol. 22, 693–703.
Voskarides K., Patsias C., Pierides A. and Deltas C. 2008 COL4A3 founder mutations in Greek-Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century. Genet. Test 12, 273–278.
Acknowledgements
We would like to thank the A. G. Leventis Foundation for funding this project.
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: Indrajit Nanda
Rights and permissions
About this article
Cite this article
Fanis, P., Efstathiou, E., Neocleous, V. et al. A novel heterozygous duplication of the SLC12A3 gene in two Gitelman syndrome pedigrees: indicating a founder effect. J Genet 98, 5 (2019). https://doi.org/10.1007/s12041-019-1056-7
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12041-019-1056-7